FDA Switch on Biologics Applauded
Agency Will Move Review For Biologic Drugs to More Experienced Division
BY MARION WEBB
Senior Staff Writer
The announcement by the Food and Drug Administration that reviews for many biological products will be moved from the agency's Center for Biologics Evaluation and Research to the Center for Drug Evaluation and Research took some biotechnology industry members by surprise...